← Back to Search

Vitamin K2

Vitamin K and Glucose Metabolism in Children at Risk for Diabetes (Vita-K 'n' Kids Study)

N/A
Waitlist Available
Led By Norman K Pollock, Ph.D.
Research Sponsored by Augusta University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks

Summary

This trial is testing whether vitamin K2 supplementation can improve carboxylation of osteocalcin and matrix Gla protein, and whether this can have an effect on markers associated with diabetes and cardiovascular disease risk.

Eligible Conditions
  • Insulin Resistance
  • High cholesterol
  • Obesity
  • Prediabetes
  • Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Body Weight Changes
Change in insulin sensitivity
Change in serum lipid concentrations
Secondary study objectives
Change in arterial stiffness (pulse wave velocity)
Change in coagulation
Change in endothelial function (Flow-mediated dilation)
+1 more

Trial Design

3Treatment groups
Active Control
Placebo Group
Group I: Low-Dose Vitamin K2 (45 mcg/d)Active Control1 Intervention
The low-dose vitamin K2 group will take one 45-mcg vitamin K2 softgel capsule and one placebo softgel capsule every day for 8 weeks.
Group II: High-Dose Vitamin K2 (90 mcg/d)Active Control1 Intervention
The high-dose vitamin K2 group will take one 90-mcg vitamin K2 softgel capsules every day for 8 weeks.
Group III: Placebo-ControlPlacebo Group1 Intervention
The placebo-control group will take one placebo softgel capsules every day for 8 weeks.

Find a Location

Who is running the clinical trial?

Yale UniversityOTHER
1,927 Previous Clinical Trials
3,031,702 Total Patients Enrolled
26 Trials studying Insulin Resistance
5,381 Patients Enrolled for Insulin Resistance
Tufts UniversityOTHER
270 Previous Clinical Trials
594,861 Total Patients Enrolled
5 Trials studying Insulin Resistance
290 Patients Enrolled for Insulin Resistance
Augusta UniversityLead Sponsor
215 Previous Clinical Trials
85,660 Total Patients Enrolled
2 Trials studying Insulin Resistance
60 Patients Enrolled for Insulin Resistance
University of Alabama at BirminghamOTHER
1,648 Previous Clinical Trials
2,344,545 Total Patients Enrolled
16 Trials studying Insulin Resistance
1,127 Patients Enrolled for Insulin Resistance
Norman K Pollock, Ph.D.Principal InvestigatorDepartment of Medicine, Medical College of Georgia, Augusta University
2 Previous Clinical Trials
430 Total Patients Enrolled
1 Trials studying Insulin Resistance
30 Patients Enrolled for Insulin Resistance
~2 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top